Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
AAV vectors are widely used in gene therapy for their strong therapeutic potential
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
Subscribe To Our Newsletter & Stay Updated